Apoptosis in HepG2 cells exposed to high glucose

Toxicology in Vitro

Volumn 24, Issue 2, 2010, Pages 387-396

  Chandrasekaran, Karthikeyan ^a   Swaminathan, Kavitha ^a   Chatterjee, Suvro ^a   Dey, Aparajita ^a  

^a ANNA UNIVERSITY   (India)

Author keywords

Apoptosis; DNA damage; HepG2; High glucose; Oxidative stress

Indexed keywords

3 NITROTYROSINE; 4 HYDROXYNONENAL; ACETYLCYSTEINE; ANTIOXIDANT; CARBONYL DERIVATIVE; CASPASE 3; GLUCOSE; GLUTATHIONE; LIPID; LIPOCORTIN 5; REACTIVE OXYGEN METABOLITE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

APOPTOSIS; ARTICLE; CELL DEATH; CELL SHAPE; CELL SIZE; CELL STRAIN HEPG2; CELL STRUCTURE; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DIABETES MELLITUS; ENZYME ACTIVITY; HUMAN; HUMAN CELL; HYPERGLYCEMIA; INCUBATION TIME; LIPID PEROXIDATION; LIVER CELL; LIVER INJURY; MICROSCOPY; OXIDATIVE STRESS; PATHOPHYSIOLOGY; SPECTROFLUOROMETRY;

ANNEXINS; APOPTOSIS; CARCINOMA, HEPATOCELLULAR; CASPASE 3; CELL LINE, TUMOR; DNA FRAGMENTATION; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUCOSE; HUMANS; L-LACTATE DEHYDROGENASE; LIVER NEOPLASMS; MANNITOL; STAINING AND LABELING; TIME FACTORS;

EID: 76749083813     PISSN: 08872333     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tiv.2009.10.020     Document Type: Article

References (37)

1. Chen Z., Seimiya H., Naito M., Mashima T., Kizaki A., Dan S., Imaizumi M., Ichijo H., Miyazono K., and Tsuruo T. PI DNA damage - ASK1 mediates apoptotic cell death induced by genotoxic stress. Oncogene 18 (1999) 173-180
2. Cusi K. Nonalcoholic fatty liver disease in type 2 diabetes mellitus. Current Opinion in Endocrinology, Diabetes and Obesity 16 (2009) 141-149
3. Dey A., and Cederbaum A.I. Geldanamycin, an inhibitor of Hsp90, potentiates cytochrome P4502E1-mediated toxicity in HepG2 cells. The Journal of Pharmacology and Experimental Therapeutics 317 (2006) 1391-1399
4. Díaz-Flores M., Ibáñez-Hernández M.A., Galván R.E., Gutiérrez M., Durán-Reyes G., Medina-Navarro R., Pascoe-Lira D., Ortega-Camarillo C., Vilar-Rojas C., Cruz M., and Baiza-Gutman L.A. Glucose-6-phosphate dehydrogenase activity and NADPH/NADP+ ratio in liver and pancreas are dependent on the severity of hyperglycemia in rat. Life Sciences 78 (2006) 2601-2607
5. Duran-Sandoval D., Mautino G., Martin G., Percevault F., Barbier O., Fruchart J.C., Kuipers F., and Staels B. Glucose regulates the expression of the farnesoid X receptor in liver. Diabetes 53 (2004) 890-898
6. Evans J.L., Goldfine I.D., Maddux B.A., and Grodsky G.M. Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. Endocrine Reviews 23 (2002) 599-622
7. Fracanzani A.L., Valenti L., Bugianesi E., Andreoletti M., Colli A., Vanni E., Bertelli C., Fatta E., Bignamini D., Marchesini G., and Fargion S. Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes. Hepatology 48 (2008) 792-798
8. Fujimoto M., Shimizu N., Kunii K., Martyn J.A., Ueki K., and Kaneki M. A role for iNOS in fasting hyperglycemia and impaired insulin signaling in the liver of obese diabetic mice. Diabetes 54 (2005) 1340-1348
9. Giugliano D., Ceriello A., and Esposito K. Glucose metabolism and hyperglycemia. American Journal of Clinical Nutrition 87 (2008) 217S-222S
10. Goh S.Y., and Cooper M.E. Clinical review: the role of advanced glycation end products in progression and complications of diabetes. Journal of Clinical Endocrinology and Metabolism 93 (2008) 1143-1152
11. Hall A.G. Glutathione and the regulation of cell death. Advances in Experimental Medicine and Biology 457 (1999) 199-203
12. Hou X., Xu S., Maitland-Toolan K.A., Sato K., Jiang B., Ido Y., Lan F., Walsh K., Wierzbicki M., Verbeuren T.J., Cohen R.A., and Zang M. SIRT1 regulates hepatocyte lipid metabolism through activating AMP-activated protein kinase. Journal of Biological Chemistry 283 (2008) 20015-20026
13. Kaneto H., Katakami N., Kawamori D., Miyatsuka T., Sakamoto K., Matsuoka T.A., Matsuhisa M., and Yamasaki Y. Involvement of oxidative stress in the pathogenesis of diabetes. Antioxidants and Redox Signaling 9 (2007) 355-366
14. Levine R.L., Williams J.A., Stadtman E.R., and Shacter E. Carbonyl assays for determination of oxidatively modified proteins. Methods in Enzymology 233 (1994) 346-357
15. Lonardo A., Carani C., Carulli N., and Loria P. 'Endocrine NAFLD' a hormonocentric perspective of nonalcoholic fatty liver disease pathogenesis. Journal of Hepatology 44 (2006) 1196-1207
16. Lowry O.H., Rosenbrough N.J., Farr A.L., and Randall R.J. Protein measurement with the Folin-phenol reagent. Journal of Biological Chemistry 193 (1951) 265-275
17. Murao K., Yu X., Imachi H., Cao W.M., Chen K., Matsumoto K., Nishiuchi T., Wong N.C., and Ishida T. Hyperglycemia suppresses hepatic scavenger receptor class B type I expression. American Journal of Physiology - Endocrinology and Metabolism 294 (2008) E78-E87
18. Nakajima K., Yamauchi K., Shigematsu S., Ikeo S., Komatsu M., Aizawa T., and Hashizume K. Selective attenuation of metabolic branch of insulin receptor - down-signaling by high glucose in a hepatoma cell line, HepG2 cells. Journal of Biological Chemistry 275 (2000) 20880-20886
19. Nicholson D.W., and Thornberry N.A. Caspases: killer proteases. Trends in Biochemical Sciences 22 (1997) 299-306
20. Palmeira C.M., Rolo A.P., Berthiaume J., Bjork J.A., and Wallace K.B. Hyperglycemia decreases mitochondrial function: the regulatory role of mitochondrial biogenesis. Toxicology and Applied Pharmacology 225 (2007) 214-220
21. Ramana K.V., Friedrich B., Bhatnagar A., and Srivastava S.K. Aldose reductase mediates cytotoxic signals of hyperglycemia and TNF-α in human lens epithelial cells. The FASEB Journal 17 (2003) 315-317
22. Rolo A.P., and Palmeira C.M. Diabetes and mitochondrial function: role of hyperglycemia and oxidative stress. Toxicology and Applied Pharmacology 212 (2006) 167-178
23. Rossini A.A., Thompson M.J., Malkani S., and Mordes J.P. Irwin and Rippe's Intensive Care Medicine. Diabetic Comas (2007), Lippincott Williams and Wilkins, Philadelphia pp. 1256-1270
24. Sauvaget D., Chauffeton V., Dugué-Pujol S., Kalopissis A.D., Guillet-Deniau I., Foufelle F., Chambaz J., Leturque A., Cardot P., and Ribeiro A. In vitro transcriptional induction of the human apolipoprotein A-II gene by glucose. Diabetes 53 (2004) 672-678
25. Shankar K., Vaidya V.S., Corton J.C., Bucci T.J., Liu J., Waalkes M.P., and Mehendale H.M. Activation of PPAR-alpha in streptozotocin-induced diabetes is essential for resistance against acetaminophen toxicity. FASEB Journal 17 (2003) 1748-1750
26. Stern, S.T., Potter, T.M., Neun, B.W., 2006. HEPG2 Hepatocyte Lipid Peroxidation Assay. Nanotechnology Characterization Laboratory-NCL Method GTA-4 Version 1.0.
27. Suh S.W., Gum E.T., Hamby A.M., Chan P.H., and Swanson R.A. Hypoglycemic neuronal death is triggered by glucose reperfusion and activation of neuronal NADPH oxidase. Journal of Clinical Investigations 117 (2007) 910-918
28. Swiecki C., Stojadinovic A., Anderson J., Zhao A., Dawson H., and Shea-Donohue T. Effect of hyperglycemia and nitric oxide synthase inhibition on heat tolerance and induction of heat shock protein 72 kDa in vivo. The American Surgeon 69 (2003) 587-592
29. Tietze F. Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. Analytical Biochemistry 27 (1969) 502-522
30. van Deursen D., Jansen H., and Verhoeven A.J. Glucose increases hepatic lipase expression in HepG2 liver cells through upregulation of upstream stimulatory factors 1 and 2. Diabetologia 51 (2008) 2078-2087
31. Wu D., and Cederbaum A.I. Alcohol, oxidative stress, and free radical damage. Alcohol Research and Health 27 (2003) 277-284
32. Younossi Z.M., Gramlich T., Matteoni C.A., Boparai N., and McCullough A.J. Nonalcoholic fatty liver disease in patients with type 2 diabetes. Clinical Gastroenterology and Hepatology 2 (2004) 262-265
33. Yu T., Robotham J.L., and Yoon Y. Increased production of reactive oxygen species in hyperglycemic conditions requires dynamic change of mitochondrial morphology. Proceedings of the National Academy of Sciences USA 103 (2006) 2653-2658
34. Yuan L., and Kaplowitz N. Glutathione in liver diseases and hepatotoxicity. Molecular Aspects of Medicine 30 (2009) 29-41
35. Zang M., Zuccollo A., Hou X., Nagata D., Walsh K., Herscovitz H., Brecher P., Ruderman N.B., and Cohen R.A. AMP-activated protein kinase is required for the lipid-lowering effect of metformin in insulin-resistant human HepG2 cells. Journal of Biological Chemistry 279 (2004) 47898-47905
36. Zhang X., Jiang B., Luo G., Nilsson-Ehle P., and Xu N. Hyperglycemia down-regulates apolipoprotein M expression in vivo and in vitro. Biochimica et Biophysica Acta 1771 (2007) 879-882
37. Zimmet P., Alberti K.G., and Shaw J. Global and societal implications of the diabetes epidemic. Nature 414 (2001) 782-787